References
- Bremer M, Klopper K, Yamini P, Bendix-Waltes R, Dork T, Karstens JH. 2003. Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: No observation of increased radiation-induced acute or late effects. Radiotherapy and Oncology 69:155–160.
- Buchholz TA, Wu X, Hussain A, Tucker SL, Mills GB, Haffty B, Bergh S, Story M, Geara FB, Brock WA. 2002. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. International Journal of Cancer 97:557–561.
- Chistiakov DA, Voronova NV, Chistiakov PA. 2008. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncologica 47:809–824.
- Ernestos B, Nikolaos P, Koulis G, Eleni R, Konstantinos B, Alexandra G, Michael K. 2010. Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay. International Journal of Radiation Oncology, Biology, Physics 76:1199–1205.
- Fernando IN, Ford HT, Powles TJ, Ashley S, Glees JP, Torr M, Grafton D, Harmer CL. 1996. Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: A prospective study of treatment practice at the Royal Marsden Hospital. Clinical Oncology (Royal College of Radiologists) 8:226–233.
- Foray N, Randrianarison V, Marot D, Perricaudet M, Lenoir G, Feunteun J. 1999. Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 18:7334–7342.
- Gaffney DK, Brohet RM, Lewis CM, Holden JA, Buys SS, Neuhausen SL, Steele L, Avizonis V, Stewart JR, Cannon-Albright LA. 1998. Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiotherapy and Oncology 47: 129–136.
- Harper JL, Franklin LE, Jenrette JM, Aguero EG. 2004. Skin toxicity during breast irradiation: Pathophysiology and management. Southern Medical Journal 97:989–993.
- Leong T, Whitty J, Keilar M, Mifsud S, Ramsay J, Birrell G, Venter D, Southey M, McKay M. 2000. Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients. International Journal of Radiation Oncology, Biology, Physics 48:959–965.
- Nieuwenhuis B, Van Assen-Bolt AJ, Van Waarde-Verhagen MA, Sijmons RH, Van der Hout AH, Bauch T, Streffer C, Kampinga HH. 2002. BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage. International Journal of Radiation Biology 78: 285–295.
- Pierce LJ, Strawderman M, Narod SA, Oliviotto I, Eisen A, Dawson L, Gaffney D, Solin LJ, Nixon A, Garber J, Berg C, Isaacs C, Heimann R, Olopade OI, Haffty B, Weber BL. 2000. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. Journal of Clinical Oncology 18: 3360–3369.
- Popanda O, Marquardt JU, Chang-Claude J, Schmezer P. 2009. Genetic variation in normal tissue toxicity induced by ionizing radiation. Mutation Research 667:58–69.
- Raabe A, Derda K, Reuther S, Szymczak S, Borgmann K, Hoeller U, Ziegler A, Petersen C, Dikomey E. 2012. Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy. Radiation Oncology 7:65.
- Shanley S, McReynolds K, Ardern-Jones A, Ahern R, Fernando I, Yarnold J, Evans G, Eccles D, Hodgson S, Ashley S, Ashcroft L, Tutt A, Bancroft E, Short S, Gui G, Barr L, Baildam A, Howell A, Royle G, Pierce L, Easton D, Eeles R. 2006. Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clinical Cancer Research 12:7025–7032.
- Son BH. 2008. Hereditary breast cancer in Korea: A review of the literature. Journal of Breast cancer 11:1–9.